Picture of Basilea Pharmaceutica AG, Allschwil logo

BSLN — Basilea Pharmaceutica AG, Allschwil News Story

0.000.00%
ch flag iconLast trade - 00:00
HealthcareAdventurousMid CapHigh Flyer

Brief: Basilea Pharmaceutica Announces Cresemba® Sales In Asia Pacific Region Trigger Sales Milestone Payment For This Region

June 17 (Reuters) - BASILEA PHARMACEUTICA AG  BSLN.S :
    * CRESEMBA® SALES IN ASIA PACIFIC REGION TRIGGER SALES
MILESTONE
PAYMENT TO BASILEA FROM PFIZER
    * UNDER AGREEMENT WITH PFIZER, BASILEA IS ELIGIBLE FOR
ADDITIONAL
REGULATORY AND SALES MILESTONE PAYMENTS OF UP TO AROUND CHF 550
MILLION, IN ADDITION TO RECEIVING MID-TEEN ROYALTIES ON SALES

Source text for Eikon:  ID:nGNEHn7cg 
Further company coverage:  BSLN.S 

 (Gdansk Newsroom)
 ((Gdansk.newsroom@thomsonreuters.com; +48 58 7696600;))

Recent news on Basilea Pharmaceutica AG, Allschwil

See all news